Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,303 total articles

Intuitive Machines SVP Executes $2.63M Stock Sale, Converts Units; Firm Posts Q4 Fiscal 2025 Shortfall

Intuitive Machines SVP Executes $2.63M Stock Sale, Converts Units; Firm Posts Q4 Fiscal 2025 Shortfall

Timothy Price II Crain, SVP and Chief Technology Officer at Intuitive Machines (LUNR), sold 150,000 shares of Class A common stock on March 19, 2026, for roughly $2.63 million under a Rule 10b5-1 plan. The transactions were executed in tranches at varying prices. On the same day he converted 150,000 Common Units into Class A shares. Separately, Int…

GAM Vice President Acquires Small Stake in Company Preferred Shares

GAM Vice President Acquires Small Stake in Company Preferred Shares

Eugene S. Stark, General American Investors Co Inc's vice president overseeing administration and financial controls, purchased 11 shares of the firm's 5.95% preferred stock on March 20, 2026, spending $274. The filing shows Stark already holds larger direct and indirect positions in the preferred series and common shares. The investment company’s …

Assurant Executive Vice President Sells $400,096 in Shares

Assurant Executive Vice President Sells $400,096 in Shares

Assurant Executive Vice President and Chief People Officer Subhashish Sengupta sold 1,900 shares of company stock on March 19 and 20, 2026, for roughly $400,096. The trades were carried out under a previously established trading plan and recorded on a Form 4 filed with the SEC. Post-sale holdings and recent company financial data are included in th…

United Therapeutics CEO Sells $4.99M in Stock as Company Reports Phase 3 Win and Launches $2B Buyback

United Therapeutics CEO Sells $4.99M in Stock as Company Reports Phase 3 Win and Launches $2B Buyback

Martine Rothblatt, Chairperson and CEO of United Therapeutics Corporation (NASDAQ: UTHR), sold 9,500 shares on March 20, 2026 under a 10b5-1 plan, realizing $4,987,386. The filing also shows she exercised options to acquire the same number of shares at $146.03 each. The company concurrently announced positive phase 3 TETON-2 results published in th…

Assurant SVP Disposes $158,235 of Stock as Insurer Posts Q4 Beat

Assurant SVP Disposes $158,235 of Stock as Insurer Posts Q4 Beat

Dimitry DiRienzo, Senior Vice President, CAO and Controller at Assurant, sold 750 shares on March 20, 2026, generating $158,235. The insurer later recorded a fourth-quarter 2025 earnings beat and sits below InvestingPro's fair value estimate despite a brief premarket dip in its share price. DiRienzo continues to hold 4,741 shares, including restric…

Bank of America and Merrill Lynch Report Small Sale and Purchase in Putnam Municipal Opportunities Trust

Bank of America and Merrill Lynch Report Small Sale and Purchase in Putnam Municipal Opportunities Trust

A regulatory filing dated March 19, 2026, shows Bank of America CORP /DE/ together with Merrill Lynch, Pierce, Fenner & Smith INC reported the sale of 50 shares of Putnam Municipal Opportunities Trust (NYSE: PMO) common stock at $10.53 per share, and the same filing records a 50-share purchase at $10.57 per share. The transaction totals were $526 f…